For its talc-based products considered carcinogenic (ANSA) US pharmaceutical giant Johnson & Johnson has proposed an $8.9 billion settlement to settle lawsuits alleging its talc-based products have caused cancer. For the New Jersey-based company, this settlement, which has yet to be approved by a court, "will fairly and efficiently resolve all litigation."
US pharmaceutical giant Johnson & Johnson has proposed an $8.9 billion settlement to settle lawsuits alleging its talc-based products have caused cancer.
For the New Jersey-based company, this settlement, which has yet to be approved by a court, "will fairly and efficiently resolve all litigation."